chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 13JUN96 & 20JUN96 pt devel hundred of lesions  consistent w/chickenpox & t102;approx 40 lesions were concentrated @ inj site;pt recovered;
Nausea for 15 minutes shortly after the vaccine, mild flushing of hands and face shortly after the shot, and fatigue for 24 hours after shot.
sciatic nerve pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-May-2021 and was forwarded to Moderna on 24-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (sciatic nerve pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SCIATICA (sciatic nerve pain). At the time of the report, SCIATICA (sciatic nerve pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Treatment Medications were reported. No concomitant medication details were reported.    Reporter did not allow further contact
General neuropathy in right arm; Tingling in fingers; numbness; sharp pains; cramping; My hand throbs; This is a spontaneous report from a Contactable Other Healthcare Professional (Patient). A 54-year-old female patient (not pregnant) received bnt162b2 (Pfizer BioNTech Covid 19 mRNA Vaccine), dose 2 via an unspecified route of administration, administered in Arm Right on 23Aug2021 15:00 at 54 years old (Lot Number: FA6780) as single dose for covid-19 immunization. Facility type vaccine was Doctor's office/urgent care. Medical history included diverticulosis, breast cancer, depression, anxiety; No Known Allergies; no COVID prior vaccination. COVID was not tested post vaccination. Concomitant medications in two weeks included venlafaxine taken for an unspecified indication, start and stop date were not reported; buspirone taken for an unspecified indication, start and stop date were not reported. No other vaccine was administered in four weeks. The patient previously received the first dose of bnt162b2 (Lot number: FA6780) on 02Aug2021 03:00 PM at 53 years old in right arm for covid-19 immunization. The patient experienced general neuropathy in right arm. Tingling in fingers, numbness, sharp pains. Tingling and cramping began in the fingertips and move gradually up her arm to her shoulder. Her hand throbs and she sometimes have stabbing pains while trying to complete daily tasks like holding on to things, writing or driving. Adverse events started from 27Aug2021. No treatment was received for the events. The outcome of the events was not recovered.; Sender's Comments: Based on temporal relationship the possibility of causal association between the events Peripheral Neuropathy and other reported events  and the suspect drug BNT162B2 cannot be excluded.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Positive COVID -19 Lab result on 01/08/2021. Employee hospitalized due to COVID weakness, cough and shortness of breath. Admitted for 5 days.
The pt returned to the office on 04/05/2002 with left thigh swelling. She received DTaP vaccine on 04/03/2002 on the left thigh. The left thigh was swollen 2" from injection site and 1" in diameter with warm to touch, red and tender to palpatation. She was diagnosed with cellulitis and placed on Augmentin. The symptoms resolved.
migraine h/a, chills, nausea 3 days p/1st vax; 10MAR92 f/u report; recovered;
Onset of rxn 1-4 days p/inject; sx included: arm sore & burning, SOB, chest pain, h/a & temp @ 104F; Referred to family MD for tx;
Reported decreased fetal movement following vaccine administration at visit 5/20/16.  Presented on 5/24/16 to L&D and diagnosed with fetal demise.
77 yr old caller got her vaccine on Tuesday march 16th her first vaccine at 230, moderna lot # 044 A GA or AUA woke up Wednesday with dizziness history corona virus in sept of 2020, asthma later on Wednesday she vomited one time feels fine today
pt had a positive COVID test on 9/15/21, pt died at home; no medical records; a post mortem COVID  swab was obtained and found to be positive on 9/25/21
Arthus type reaction right deltoid (warm, firm, red, tender) given Tylenol for pain (pt preference).
Information has been received from a physician concerning a 13 year old patient who on an unspecified date was vaccinated with a second dose of VARIVAX (Merck) (Lot number unspecified). The physician reported that the patient broke out with the chicken pox within the last few weeks (as recent as 12-APR-2010). At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. This is one of several reports received from the same source. Additional information has been requested.
Fever, start on 07/20/07, pharyngitis, start on 07/21/07, headache start on 07/20/07, ulcers and blisters on mouth start 07/24/07, gum enlargement and bleeding, start on 07/25/07, pain in neck, body ache, pain at injection site.
Same Day: wet bed for first time in years. Next day: complained of irregular heartbeat, but it went away after a couple of minutes. 2nd day: complained of irregular heart beat, fast then stopping then slow, for over 10-15 minutes. We went to the ER and did a followup appointment the next day and came home with a heart monitor for the next 30 days to track it. When I looked online, the correlation for arrhythmia and MMR was grim but no doctors were interested or took it seriously. He seems to be doing fine now but tracking it closely.
Mom called on 8/11, two days after the injection to report the initial swelling. The progression/regression of the swelling where it went to ant chest wall/breast happened Sunday. Mom reports that after the vaccine in the right arm which we recorded as the MENACTRA, he had swelling in his upper arm and shoulder with extension to the axilla with no lymphadenopathy. He complained of pain in the arm and axilla but no itch. The following day the swelling in the shoulder had decreased and the swelling had fallen to the level of the breast. I told mom that it sounded like a local reaction and not an allergic reaction because there was no pain. I told mom we would do  a VAERS report.
Narrative: 88yo male patient dieed on 5/11/2021. No information available regarding pt's death outside of agency facilities. Pt with Hx of AFIB and CAD followed by outside Mds. Pt had received covid vaccine (J&J) on 5/11/2021. Not able to assess if death related to covid vaccine but likely not related to the vaccinations due to pt's advanced age and length of time from vaccine administration.
Blood clot in leg; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROMBOSIS (Blood clot in leg) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039KZ014) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No reported medical history.).    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced THROMBOSIS (Blood clot in leg) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (Blood clot in leg) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment information was not provided.  Company Comment  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt recv vax; in eve, fussy w/ fever; red, knot on pt's rt leg;
Pt developed mild lip/tongue swelling and tongue numbness. No airway issues. Same symptoms happened with first dose. Symptoms began 20 minutes after vaccine. Bendaryl 50mg PO was given and pt symptoms began to improve.
Patient was sitting in chair not breathing and unresponsive. His wife and myself lowered him to the floor. He was still unresponsive, I told my tech to call 911. I started to do CPR but with slight pressure on the chest he opened his eyes. I stopped and asked him if he could breathe, he replied yes he could. I continued asking him questions until EMT arrived. They took him to the hospital.
On Tuesday afternoon during the last hour of work I started to feel "off", just like something was being worked on in my body. When I got home I took two at-home COVID19 test and it was positive but the other one was negative. That night I was awakened by a fever with chills and sweats and a really bad headache. I took some TYLENOL which helped the fever but not the headache. I took another COVID19 test in the morning and it was immediately positive. I called into work sick, and called my PCPs office. The pharmacist called me and asked if I wanted PAXLOVID, but I declined. My symptoms were nasal congestion, headache, low fever averaging 100-101, and body aches. On the 4th day I could tell it had peaked and was not worsening, and started to improve. I still had a fever on my 6th day, of 100 but the next day I was better. I still have some nasal congestion but its resolving.
Generalized aching; Diarrhea; Intermittent Fever; This spontaneous case was reported by a physician and describes the occurrence of PAIN (Generalized aching), DIARRHOEA (Diarrhea) and PYREXIA (Intermittent Fever) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Hidradenitis suppurativa.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced PAIN (Generalized aching), DIARRHOEA (Diarrhea) and PYREXIA (Intermittent Fever). At the time of the report, PAIN (Generalized aching), DIARRHOEA (Diarrhea) and PYREXIA (Intermittent Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication information was provided.   This case was linked to MOD-2021-086818, MOD-2021-086711, MOD-2021-087217, MOD-2021-087097, MOD-2021-085006 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow-up Received on 06-MAY-2021 New Events Pyrexia, Diarrhea, added. Updated outcome of the event Body Ache from unknown to Recovered. updated action taken for the drug from Unknown to Discontinued. updated verbatim of Aches to Generalized aches; Sender's Comments: 21K-163-3881504-00 was considered a duplicate of AER 21K-163-3836205-00. All the information from cases was  merged into AER 21K-163-3836205-00 and AER 21K-163-3881504-00 was invalidated. MOD-2021-086818:Case received in same source doc email  MOD-2021-086711:Case received in same source doc email  MOD-2021-087217:Case received in same source doc email  MOD-2021-087097:Case received in same source doc email MOD-2021-085006:Case received in same source doc email
Pt presented to clinic for nurse visit. Has softball size red warm to touch area on left thigh, blisters in center, with another area off to side @ 11 o clock, areas marked with permanent marker states hurts and itchy, mom hasn't noticed him scratching. Dr. informed and pt placed on her schedule. Cellulitis of left lower extremity. It is unclear if this is secondary to a reaction to the vaccine vs a cellulitis so will begin treatment with cephalexin to treat a possible cellulitis. Used a marker to outline the erythema, and pt will return tomorrow for a RN visit to ensure that his symptoms are improving. Dr. also examined the area since she will be in the office tomorrow to re-evaluate patient at that time. Instructed to go to the ER if he develops any new symptoms or has any worsening symptoms. KEFLEX 250 mg/5 mL suspension; Take 500 mg (10 ml) four times a day for 7 days.
runny nose; had to take 2 naps in one day; This is a spontaneous report from a contactable consumer (patient wife) reported for male Patient (reporter husband) via Medical Information Team.   A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced runny nose and had to take 2 naps in one day. The outcome of the events was unknown.  Communication: Report 2 of 2. Caller was warm transferred to (name)  Medical inquiry was addressed in Report 1.  The lot number for the vaccine (BNT162B2), was not provided and will be requested during follow up.
NONE:  PROVIDED EXPIRED VACCINE (EXPIRED 2 DAYS PRIOR); DETERMINING IF PATIENT NEEDS TO BE REDOSED OR NOT.
Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; Red, raised, hot, painful, itchy blotches of rash throughout torso (front and back), thighs, neck and lower left arm; raised rash; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 11Apr2021 at 16:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, allergy to sulpha based drugs, IVP dye, some shellfish. Concomitant medications included levothyroxine sodium (SYNTHROID), azelastine hydrochloride (ASTELIN), lorazepam (MANUFACTURER UNKNOWN), multivitamin (MANAFACTURER UNKNOWN), calci (MANAFACTURER UNKNOWN) all from an unknown date for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Mar2021 at 16:00 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 10:00 the patient experienced red, raised, hot, painful, itchy blotches of rash throughout torso front and back, thighs, neck and lower left arm. The clinical outcome of events red rash, raised rash, skin warm, painful rash, itchy rash, blotchy rash was recovered on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Saturday morning patient had a seizure while at home, mother reports that seizure lasted approximately 1 minute, patient's mother immediately put patient in tub, and called firefighters, when firefighters arrived they stated that patient's temperature was 94 F. Then on 01/31/17, patient had a temperature of 100.4 F, and was just staring blank, patient was taken to ER for evaluation.
This spontaneous report as received from a nurse refers to a 68 years old female patient with allergy to codeine and no medical history. The patient was received 0.65 ZOSTAVAX (lot # 0240AE, expires 15-MAR-2013) on 18-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. The nurse said that the patient reported that her arm was red and swollen at the injection site, when she woke up on 19-JUL-2012. Nurse reported that the patient was seen in the office on 19-JUL-2012, and that an area measuring one by one-and-a-half inches surrounding the injection site appeared red, warm and swollen. Nurse reported that the patient was treated with cortisone cream at the time of the office visit. Nurse reported that the patient returned to the practice on 20-JUL-2012, that the area of redness, warmth and swelling had grown to 2 inches, and that the patient was then administered and 80 mg DEPOMEDROL injection. There was no laboratory studies performed. At the time of the report, the outcomes of adverse events were reported as recovering/resolving. Additional information has been requested.
red, hot to the touch, very painful, swelling. Prescription given for pain meds and antibiotic and prednisone. Pt seen 1 week ago for WWE and was given PREVNAR vaccine. She stated the next day she began having pain in the arm vaccine was given. She developed redness, swelling and warmth over the last 3-4 days. She woke up this morning and pain is getting worse. Her husband had the same vaccine the same day and has no symptoms.
Moderna COVID-19 Vaccine EUA:  Patient reported on 11/11/2021 that she developed a large, red hot area on left arm subsequent to vaccination.  Concern for vaccine administration site being too low.  Area of redness begins 12.0cm down from Humeral/Scapular joint, and measures 8.0cm long X 9,0cm wide.  it is swollen, red, and warm to the touch.  Employee states that it has been improving.  She first noticed it 11/14/2021 @ 0000.  Employee reported to the Nurse to look at arm.  It appears improved on 11/12/21 from initial presentation on 11/11/2021.
WHOLE BODY ACHES, MUSCLE ACHES, HEADACHE, FEVER, FEELS WEAK AND FEELS LIKE THE FLU; SKIN FEELS SENSITIVE; DIARRHEA; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: seizure, and other pre-existing medical conditions included: Patient had no known drug allergies and had a history of seizures which excluded her from taking ibuprofen. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-NOV-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 12-NOV-2021, the patient experienced whole body aches, muscle aches, headache, fever, feels weak and feels like the flu. On 12-NOV-2021, the patient experienced skin feels sensitive. On 12-NOV-2021, the patient experienced diarrhea. Laboratory data included: Body temperature (NR: not provided) 101 F. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from skin feels sensitive, and diarrhea on NOV-2021, and had not recovered from whole body aches, muscle aches, headache, fever, feels weak and feels like the flu.  This report was non-serious.
Pediatric patient was sitting in post vaccination area when he said his arm hurt and passed out.  Patient was pale and not responsive but breathing and had a pulse.  I laid him down on the floor and he came to but felt nauseous and looked like he was going to pass out again. 911 responded and took him to the nearest ER.
inc in temp x 1 wk; 99-100 swelling & erythema @ inject site x 1 wk; encouraged to use ice to siet & given Pediprofen for temp & pain;
This spontaneous report as received from a pharmacist refers to a currently 65 year old female patient. The patient had no drug reactions or allergies. The patient's pertinent medical history and concurrent conditions were unknown by the reporter. On 19-APR-2013 the patient was vaccinated with a dose of ZOSTAVAX 0.65 ml, subcutaneously, (Anatomical location, lot number and expiration date were not provided). Concomitant therapies included gabapentin, acetaminophen (+) hydrocodone bitartrate,  HYZAAR, ZOCOR and pantoprazole. On an unknown date the patient experienced "breakouts of a rash, around the tailbone region" (rash), since receiving the ZOSTAVAX. The pharmacist was informed by the patient, that the patient's physician informed patient that the event were probably from the ZOSTAVAX. No product quality complaint was involved. The outcome of rash and the reporter causality between the event and the therapy with ZOSTAVAX were unknown. Additional information has been requested.
Fever, headache, fatigue/tiredness, chills, and body aches occurred after falling asleep for the night on the day the vaccine was administered. Fever, headache, and chills were gone 24 hours after receiving the vaccine. Tiredness, fatigue, and general weakness persisted for several days. Chronic Back pain has become more intense and still present to a significant degree .
Pt received a Pfizer Bivalent dose from a vial that was left out of the refrigerator over night.  Before patient left the clinic, the MA recognized this and called the patient back and he received a correct dose the same day from a new properly stored vial.
Pt recvd 2 doses of Engerix-B & recvd dose 1 NOV91 & dose 2 DEC91 p/2nd dose  & exp fever & joint discomfort (achiness); fever reached 104; talked to MD; took APAP; fever broke the next day;